Earnings Snapshot: Cracker Barrel’s Hidden 5%+ Dividend Yield

September 13, 2017

Cracker Barrel is holding its share-price uptrend nicely. The company is one of our favorite restaurants thanks in part to its differentiated niche and country store concept. Special dividend payouts make it a hidden income gem, in our view. By Brian Nelson, CFA Here’s what we wrote last May, “Cracker Barrel Hits the Trifecta!:” Cracker Barrel’s (CBRL) store-within-a-restaurant concept is one of the best revenue-generators per square foot around, and it is run by a management team that knows the importance of the dividend to income investors. We continue to believe it is a great fit for the Dividend Growth Newsletter portfolio and an often overlooked one in light of its preponderance of special dividends that often fly under the

Target, Kroger Launch Counterattack on Amazon-Whole Foods; Industry Earnings to Shrink

September 12, 2017

Image Source: Valuentum The pricing war has begun, but it may take years before we see the final effects. Only the strongest may come out ahead, and only those already focusing on giving customers the very best value proposition at the lowest prices may retain share. By Brian Nelson, CFA The grocery store business is now on a path of significant change in the wake of news that Amazon (AMZN) would acquire upscale organic grocer Whole Foods (WFM). The online retailing giant has wasted little time in resetting the product pricing environment at Whole Foods, and we expect that other grocers will have to follow. The group had already been on high alert given recent language from Kroger (KR), suggesting

Canakinumab Posts Some Impressive Data For Novartis

September 11, 2017

We remain impressed with the depth of the clinical pipeline that is currently being brought out to market by the Dividend Growth Newsletter portfolio idea Novartis. We closely follow the data delivered from clinical trials to gauge the potential for the pipeline; in the case of Novartis, we feel the strength of the emerging pipeline bodes very well for continued dividend growth over the next few years. In this piece, we will detail the clinical results for Canakinumab, as we feel the molecule will nicely complement Novartis’ burgeoning cardiovascular unit. By Alexander J. Poulos Canakinumab   Image source: Novartis Cardiovascular Disease (CVD) remains one the largest areas of need based on the sheer number of patients afflicted with some form

Dividend Increases/Decreases for the Week Ending September 8

September 9, 2017

Below we provide a list of firms that raised/lowered their dividends during the week ending September 8. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Anthem (ANTM): now $0.70 per share quarterly dividend, was $0.65. BHP Billiton (BHP): now $0.86 per ADS semi-annual dividend, was $0.80. BIOQUAL (BIOQ): now $0.60 per share annual dividend, was $0.45. Blue Hills Bancorp (BHBK): now $0.15 per share quarterly dividend, was $0.05. Brady (BRC): now $0.2075 per share quarterly dividend, was $0.205. Brinker (EAT): now $0.38 per share quarterly dividend, was $0.34. Clough Global Allocation

Fair Value Estimates of Stocks In Our Coverage Universe

September 9, 2017

Use the download below to view the fair value estimates of companies in our coverage universe. How to filter data in Excel? Click here. Download the screener or build your own screener here (xls). Important Note: The data and rankings are updated frequently and are current as of the date of this download. Valuentum may have updated the stock and dividend reports of companies after the published date of this download. Members should view the rankings in this download as a starting point for further research and always access the individual stock page of each desired company on our website for its most recent ratings, metrics, and valuation information. If you have any questions about our services, please contact us at info@valuentum.com. Note on

Rank Our Coverage Universe By Valuentum Buying Index Rating

September 9, 2017

  Please select the image below to download our latest study on the Valuentum Buying Index. << The Seven Most Important Considerations of the Valuentum Buying Index << Why Portfolio Holdings Can Sometimes Have Low VBI Ratings << The Best Way to Use the Valuentum Process ——————– Use the download below to rank our coverage universe by Valuentum Buying Index rating. How to filter data in Excel? Click here. Download the screener or build your own screener here (xls). Important Note: The data and rankings are updated frequently and are current as of the date of this download. Valuentum may have updated the stock and dividend reports of companies after the published date of this download. Members should view the rankings in

The Wisdom of Oaktree’s Howard Marks

September 8, 2017

Image Source: emmolos The latest memo from Oaktree’s Howard Marks here should be read and then read again. The section on passive investing is an absolute treasure. “Passive investing is done in vehicles that make no judgments about the soundness of companies and the fairness of prices.  More than $1 billion is flowing daily to “passive managers” (there’s an oxymoron for you) who buy regardless of price.  I’ve always viewed index funds as “freeloaders” who make use of the consensus decisions of active investors for free.  How comfortable can investors be these days, now that fewer and fewer active decisions are being made?” — Howard Marks, Oaktree Capital Financial Tech Services: ACIW, EPAY, FDC, FIS, FISV, FLT, GPN, MA, MELI,

Adviser Fees on Indexed Assets Can Eat Up Your Nest Egg?

September 7, 2017

Indexing sounds like an easy way to track the market’s performance, but if your indexed assets are held in financial advisors’ accounts, it can come with a big cost: significant underperformance. Over 20 years, we estimate in this hypothetical example that the cumulative cost as a result of a 1% annual financial advisor fee on indexed assets can amount to as much as 66% of a saver’s initial investment — just for holding an index fund. Please be careful out there!

Why Won’t GM Break Out Already?

September 7, 2017

What is it going to take for General Motors to catapult to new heights? By Brian Nelson, CFA August was a busy month for the auto makers. Following General Motors’ (GM) fantastic second-quarter results in late July, we thought shares of the auto giant would have surged higher, but they have been stuck in neutral, despite what we consider to be a very, very attractive valuation and an equally attractive dividend yield. Read why we think “General Motors May Offer an Incredible Opportunity (July 2017).” Where Tesla (TSLA) and Ferrari (RACE) are trading at rather high valuation multiples, poor GM can’t even get a double-digit multiple on current-year earnings, despite what we consider to be a solid balance sheet. What

First Harvey, Now Irma

September 6, 2017

Image Source: NASA Goddard Space Flight Center. NASA Sees Irma Strengthen to a Category 5 Hurricane. This visible light image of Hurricane Irma was captured by NOAA’s GOES East satellite as it strengthened to a Category 5 hurricane in the Central Atlantic Ocean on Sept. 5 at 7:45 a.m. EDT (1145 UTC). NASA and NOAA satellites have been providing valuable satellite imagery to forecasters at the National Hurricane Center, and revealed that Hurricane Irma has strengthened to a Category 5 hurricane on Sept. 5 around 8 a.m. EDT (1200 UTC). Credits: NASA/NOAA GOES Project. Hurricane season 2017 has not been kind to insurers.  By Brian Nelson, CFA What a disaster-of-a-hurricane-season 2017 is shaping up to be. Our hearts and thoughts go out to

Previous Next

About Our Name

But how, you will ask, does one decide what [stocks are] "attractive"? Most analysts feel they must choose between two approaches customarily thought to be in opposition: "value" and "growth,"...We view that as fuzzy thinking...Growth is always a component of value [and] the very term "value investing" is redundant.

                         -- Warren Buffett, Berkshire Hathaway annual report, 1992

At Valuentum, we take Buffett's thoughts one step further. We think the best opportunities arise from an understanding of a variety of investing disciplines in order to identify the most attractive stocks at any given time. Valuentum therefore analyzes each stock across a wide spectrum of philosophies, from deep value through momentum investing. And a combination of the two approaches found on each side of the spectrum (value/momentum) in a name couldn't be more representative of what our analysts do here; hence, we're called Valuentum.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Valuentum Exclusive publication, ESG Newsletter, and any reports, data and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, data or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, and independent contractors may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, ESG Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Valuentum Exclusive publication and additional options commentary feature, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.